Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NormOxys Inc.

www.normoxys.com

Latest From NormOxys Inc.

Index Ventures Pledges 10 Million Euros To Fund Mind-NRG's CNS Candidate

Index Ventures on Oct. 27 pledged up to €10 million ($13.4 million) to Swiss start-up Mind-NRG in the latest example of the venture capitalist's asset-centric financing model.
BioPharmaceutical Business Strategies

Recent Financings of Private Companies (07/10)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

NormOxys Inc.

The founders of NormOxys are working to commercialize molecules similar to those that give migratory birds the fortitude to fly thousands of miles. When the compound inositol pentaphosphate binds to the protein hemoglobin, its presence helps release up to three of the four oxygen molecules that hemoglobin picks up in the lungs and carries out to the body. NormOxys is betting that its lead candidate can help elevate oxygen levels in human tissues that lack it, and so become a treatment for a range of disorders, from heart failure to diabetic retinopathy, traumatic blood loss, and even cancer.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NormOxys Inc.
  • Senior Management
  • Martin Tolar, MD, PhD, Pres. & CEO
    Claude Nicolau, PhD, CSO
    Conrad Bletzer, Treas.
    John A Hey, PhD, SVP, Preclinical & Early Dev.
  • Contact Info
  • NormOxys Inc.
    Phone: (339) 686-7354
    16 Laurel Ave., Ste. 150
    Wellesley, MA 02481
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register